Zydus Lifesciences Hits Day Low at Rs 990.55 Amid Price Pressure

Zydus Lifesciences, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable decline today, with shares dropping by 3.07% as of September 26, 2025. The stock opened lower, reflecting a loss of 2.78%, and reached an intraday low of Rs 990.55. This marks the third consecutive day of losses for the company, accumulating a total decline of 4.15% over this period.
The stock's performance today aligns with the broader market trend, as the Sensex also faced a downturn, trading down by 0.37%. Zydus Lifesciences has shown high volatility, with an intraday volatility rate of 65.68%, indicating significant price fluctuations throughout the trading session.

In terms of moving averages, Zydus Lifesciences is currently positioned above its 50-day, 100-day, and 200-day moving averages, yet remains below its 5-day and 20-day moving averages. Over the past year, the stock has seen a decline of 7.73%, contrasting with the Sensex's decrease of 5.83%. Despite today's challenges, Zydus Lifesciences continues to be a significant entity within its industry.